Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

被引：0
|
作者：
Parind B. Patel
Stephen J. Brett
David O’Callaghan
Aisha Anjum
Mary Cross
Jane Warwick
Anthony C. Gordon
机构：
[1] Imperial College Healthcare NHS Trust,Centre for Perioperative Medicine and Critical Care Research
[2] Imperial College London,Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer
[3] Imperial College London,Imperial Clinical Trials Unit, School of Public Health, Faculty of Medicine
[4] University of Warwick,Warwick Clinical Trials Unit
来源：
Intensive Care Medicine | 2020年 / 46卷
关键词：
Methylnaltrexone; Constipation; Laxatives; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 755
页数：8
相关论文
共 50 条
  • [41] Methylnaltrexone: Treatment for Opioid-induced Constipation-Not Convinced Yet Response
    Baumrucker, Steven J.
    Licup, Nerissa
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2011, 28 (04): : 291 - 291
  • [42] Subcutaneous Methylnaltrexone Treatment of Opioid-Induced Constipation in Adults with Rheumatic Conditions
    Moreland, Larry
    Brookfield, Rowe
    Laitman, Adam
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2474 - 2476
  • [43] Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients
    Tobben, Daniel
    Carpenter, Sheniece
    Kolar, Rachel
    Merritt, Tyler
    Young, Tramaine
    Hauser, Paloma
    Collier, Tia
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (07) : 678 - 684
  • [44] NALOXONE VERSUS METHYLNALTREXONE FOR OPIOID-INDUCED CONSTIPATION IN CRITICALLY ILL PATIENTS
    Habeeb, Ehsan
    Tran, Lena
    Goodberlet, Melanie
    Lupi, Kenneth
    Dube, Kevin
    Degrado, Jeremy
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 268 - 268
  • [45] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
    Masanori Mori
    Yongli Ji
    Santosh Kumar
    Takamaru Ashikaga
    Steven Ades
    International Journal of Clinical Oncology, 2017, 22 : 397 - 404
  • [46] EFFICACY OF SUBCUTANEOUS METHYLNALTREXONE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN SUBGROUPS OF PATIENTS WITH CHRONIC, NONMALIGNANT PAIN
    Duerden, Marc
    Schulman, Seth
    Tzanis, Evan
    Zhang, Haiyang
    Manley, Amy
    Randazzo, Bruce
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 267 - 268
  • [47] Methylnaltrexone for Refractory Opioid-Induced Constipation in Hospitalized Cancer Patients-A Highly Effective Treatment
    Harris, David
    Kalir, David Z.
    Chevalier, Cory A.
    Dobbie, Krista R.
    Fielding, Flannery
    Lee, Ruth L.
    Makhoul, Ahed
    McInnes, Susan
    Neale, Kyle
    Rybicki, Lisa
    Robbins-Ong, Melanie
    Neuendorf, Kathleen
    Najafi, Sina
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2021, 61 (03) : 650 - 650
  • [48] How safe and effective is methylnaltrexone for the treatment of opioid-induced constipation in advanced illness?
    Foss, Joseph
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (01): : 12 - 13
  • [49] How safe and effective is methylnaltrexone for the treatment of opioid-induced constipation in advanced illness?
    Joseph Foss
    Nature Clinical Practice Gastroenterology & Hepatology, 2009, 6 : 12 - 13
  • [50] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
    Mori, Masanori
    Ji, Yongli
    Kumar, Santosh
    Ashikaga, Takamaru
    Ades, Steven
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) : 397 - 404
12345